1H NMR spectroscopic study of blood serum for the assessment of liver function in liver transplant patients

Journal of Gastrointestinal and Liver Diseases

Volumn 18, Issue 3, 2009, Pages 329-336

  Tripathi, Pratima ^a   Bala, Lakshmi ^a   Saxena, Rajan ^b   Yachha, S K ^b   Roy, Raja ^a   Khetrapal, C L ^a  

^a Center for Bio Medical Magnetic Resonance Lucknow   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

1H NMR; Amino acids; Liver transplantation; Serum metabolic profile

Indexed keywords

ALANINE; ASPARAGINE; GLUTAMINE; HISTIDINE; LACTIC ACID; LYSINE; METHIONINE; PHENYLALANINE; TYROSINE; AMINO ACID;

ADOLESCENT; ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT DYSFUNCTION; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLITE; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM; UREA CYCLE; BLOOD; LIVER; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AMINO ACIDS; CHILD; CHILD, PRESCHOOL; HUMANS; LACTIC ACID; LIVER; LIVER TRANSPLANTATION; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED;

EID: 73949102432     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Sokal EM, Goldstein D, Ciocca M, et al. End-stage liver disease and liver transplant: current situation and key issues. J Pediatr Gastroenterol Nutr 2008; 47: 239-246.
2. Aw MM, Phua KB, Ooi BC, et al. Outcome of liver transplantation for children with liver disease. Singapore Med J 2006; 47: 595-598.
3. Thapa BR, Walia A. Liver function tests and their interpretation. Indian J Pediatr 2007; 74: 663-671.
4. Tarantino G. From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike? World J Gastroenterol 2007; 13: 4917-4923.
5. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007; 13: 207-214.
6. von Schonfeld J, Erhard J, Beste M, et al. Conventional and quantitative liver function tests after hepatic transplantation: a prospective long-term follow-up. Transpl Int 1997; 10: 212-216.
7. Jochum C, Beste M, Penndorf V, et al. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl 2006; 12: 544-549.
8. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids. Ann Rep NMR Spectrosc 1999; 38: 1-88.
9. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-1189.
10. 1H NMR spectroscopic method for diagnosis of malabsorption syndrome: a pilot study. NMR Biomed 2004; 17: 69-75.
11. 1H NMR spectroscopy. Magn Reson Med 2006; 56: 738-744.
12. Paczkowska A, Toczylowska B, Nyckowski P, et al. High resolution 1H nuclear magnetic resonance spectroscopy analysis of bile samples obtained from a patient after orthotopic liver transplantation: new perspectives. Transplant Proc 2003; 35: 2278-2280.
13. Gibelin H, Eugene M, Hebrard W, Henry C, Carretier M, Hauet T. A new approach to the evaluation of liver graft function by nuclear magnetic resonance spectroscopy. A comparative study between Euro-colllins and University of Wisconsin solutions. Clin Chem Lab Med 2000; 38: 1133-1136.
14. Vilca Melendez H, Rela M, Setchell KD, Murphy GM, Heaton ND. Bile acids analysis: a tool to assess graft function in human liver transplantation. Transpl Int 2004; 17: 286-292.
15. 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed 2006; 19: 521-526.
16. Ranjan P, Gupta A, Kumar S, et al. Detection of new amino acid markers of liver trauma by proton nuclear magnetic resonance spectroscopy. Liver Int 2006; 26: 703-707.
17. Singh HK, Yachha SK, Saxena R, et al. A new dimension of 1H-NMR spectroscopy in assessment of liver graft dysfunction. NMR Biomed 2003; 16: 185-188.
18. Serkova NJ, Zhang Y, Coatney JL, et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 2007; 83: 517-521.
19. Feldman M, Friedman LS, Sleisenger MH. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Vol 2, 7th Edn, Philadelphia: Saunders, 2002.
20. Guyton AC. The liver as an organ. In: Textbook of Medical Physiology. 8th Edn, Philadelphia: Saunders, 1991, 771-776.
21. Teahan O, Gamble S, Holmes E, et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal Chem 2006; 78: 4307-4318.
22. Meiboom S, Gill D. Modified spin echo method for measuring nuclear relaxation times. Rev Sci Instrum 1958; 29: 688-691.
23. 1H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods. NMR Biomed 2008; 21: 606-614.
24. Tang H, Wang Y, Nicholson JK, Lindon JC. Use of relaxation-edited one-dimensional and two-dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 2004; 325: 260-272.
25. Barba I, de Leon G, Martin E, et al. Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease. Magn Reson Med 2008; 60: 27-32.
26. Graham GD, Blamire AM, Howseman AM, et al. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke 1992; 23: 333-340.
27. Nelson DL, Cox MM. Lehninger Principles of Biochemistry. New York: Macmillan Worth Publishers, 2003.
28. Mandell MS, Wachs M, Niemann CU, Henthorn TK. Elimination of indocyanine green in the perioperative evaluation of donor liver function. Anesth Analg 2002; 95: 1182-1184.
29. Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2001; 23: 81-92.
30. Aguirre A, Yoshimura N, Westman T, Fischer JE. Plasma amino acids in dogs with two experimental forms of liver damage. J Surg Res 1974; 16: 339-345.
31. Tietge UJ, Bahr MJ, Manns MP, Boker KH. Plasma amino acids in cirrhosis and after liver transplantation: influence of liver function, hepatic hemodynamics and circulating hormones. Clin Transplant 2002; 16: 9-17.
32. Miller LL. The role of the liver and the non-hepatic tissues in the regulation of free amino acids in the blood. In: Amino acids Pool. Amsterdam: Elsevier, 1970, 708-721.
33. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72: 483-487.
34. Tietge UJ, Bahr MJ, Manns MP, Boker KH. Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl Int 2003; 16: 1-8.
35. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW. Aromatic amino acid metabolism during liver failure. J Nutr 2007; 137(6 Suppl 1): 1579S-1585S.
36. Guyton AC. Insulin, Glucagon and Diabetes Mellitus. In: Textbook of Medical Physiology. 8th Edn, Philadelphia: Saunders, 1991, 855-867.
37. Soeters PB, Fischer JE. Insulin, glucagons, amino acid imbalance, and hepatic encephalopathy. Lancet 1976; 2: 880-882.
38. Saunders SJ, Truswell AS, Barbezat GO, Wittman W, Hansen JD. Plasma free amino acid pattern in protein-calorie malnutrition. Reappraisal of its diagnostic value. Lancet 1967; 2: 795-797.